In the United States (US), the estimated annual incidence of neuroendocrine tumors is approximately 7 cases per 100,000 individuals. Overall, more than 170,000 people are living with ...

Lutetium Lu 177 vipivotide tetraxetan is under clinical development by Advanced Accelerator Applications and currently in Phase III for Metastatic Prostate Cancer. According to GlobalData, Phase III ...

Scientists at Universidade Federal Rural do Rio de Janeiro (UFRRJ) have reported a novel multitarget-directed ligand (MTDL) targeting butyrylcholinesterase (BChE) with potential for development as an ...

The company also announced that the FDA allowed an amendment to the protocol for the US Expanded Access Program (EAP) for lutetium Lu 177 dotatate (Lutathera®) to permit enrollment of patients ...

Lutetium Lu 177 dotatate is under clinical development by Advanced Accelerator Applications and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase II drugs for Small-Cell ...

Like canaries in coal mines, start-ups are small and sensitive - and in 2025 they will continue to set a course for the wider economy Some EU staff to receive €500 monthly payment from January, but ...

Bruce Power and Isogen (a partnership between Kinectrics and Framatome) have completed the installation of an Isotope Production System (IPS) at unit 7 of Canada’s Bruce NPP making it the first power ...